Tyler Cowen on the price of Ozempic.Problems with the OMB’s social welfare function. Link between alcohol and cancer. Disparities in the rural-urban life expectancy.Why will Part D plans “…move drugs that are selected for [MFP] negotiation into a higher cost-sharing tier”?
February 27, 2026
- Generate Biomedicines’ IPO Brings In $400M for Pivotal Tests of Severe Asthma Drug
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Where the Patient Experience Is Heading – And 3 Ways Healthcare Providers Can Meet That Moment
- Regulating Healthcare AI? Look To E-Prescribing
Headlines
